Technology
Health
Pharmaceutical

Roche

$33.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (0.71%) Today
$0.00 (0.00%) As of 4:14 PM EDT after-hours

Why Robinhood?

You can buy or sell Roche and other stocks, options, ETFs, and crypto commission-free!

About RHHBY

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. Read More The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. RHHBY is listed on the OTCQX International Premier market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
94,442
Headquarters
Basel, Basel-Stadt (Basle Town)
Founded
1896
Market Cap
187.16B
Price-Earnings Ratio
21.35
Dividend Yield
2.22
Average Volume
1.02M
High Today
$33.95
Low Today
$33.53
Open Price
$33.69
Volume
989.61K
52 Week High
$35.90
52 Week Low
$28.74

Collections

Technology
Health
Pharmaceutical
Europe (Non-UK)
Europe

RHHBY News

Reuters17h

Roche takes fight against Amgen’s biosimilars for Avastin, Herceptin to Fed Circuit

56

More RHHBY News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.